The mTORC2 component SIN1 post-transcriptionally regulates TYMS levels and modulates P53 activity in response to 5-FU chemotherapy

Key Points

• Post-transcriptional regulation of TYMS affects P53 activity during 5-FU chemotherapy.
• Key metric shows alteration of TYMS levels associated with varied P53 responses.
• Analysis of interactions within the mTORC2 pathway highlights SIN1's significant regulatory role.
• Findings suggest that targeting SIN1 may enhance the effectiveness of chemotherapy treatments.